Updates From Rhia Ventures

Find recent and archived press releases, and discover the latest news about our company, our investments, and our people.


APRIL 24, 2023

Rhia Ventures Issues Statement on Supreme Court’s Mifepristone Decision

The decision by the highest court to leave the FDA’s approval in place allows mifepristone to remain on the market, for now.

APRIL 8, 2023

Rhia Ventures Issues Statement on Mifepristone Rulings

Conflicting federal rulings on the legal status of mifespristone further complicate the legal landscape of abortion care in the US.

JANUARY 24, 2023

Shareholders File Numerous Proposals Addressing Access to Reproductive Health Care for 2023 Proxy Ballots

In coordination with Rhia Ventures, investors have filed thirty-one (31) shareholder proposals addressing the intersections between corporate policy and reproductive health care, more than doubling the volume of last year’s activity.

JANUARY 14, 2022

Shareholder Proposals Challenge Companies on Support for Politicians Opposing Abortion Access, Progress on Climate, Voting Rights

Institutional investors, in coordination with Rhia Ventures, have filed 11 shareholder proposals for the 2022 proxy season that address the misalignment between corporation’s stated values and their support for politicians and political groups who undermine them.

April 13, 2021

Shareholders Challenge Pfizer, The Home Depot, and JPMorgan Chase on Values Misalignment: Proposals Say Political Spending and Corporate Values Are at Odds

Company reputation is at risk in real time; backlash rising against companies’ support for politicians who back voter suppression, embrace the “stolen election” narrative, restrict access to healthcare, and take other ill-advised stands.

JANUARY 21, 2020

Report: Comprehensive Reproductive Health Care Essential for Employees and Corporate America’s Bottom Line

A groundbreaking new report, that connects how access to comprehensive reproductive health care impacts a company’s bottom line and the corporate workforce.